Tests

Clinically Actionable Pharmacogenetic Tests

Genelex currently offers 28 clinically actionable pharmacogenetic tests to help physicians target treatment and medications to patient’s genetics.  Studies have shown that incorporating genetic factors into the prescribing process can help improve efficacy and reduce adverse effects.  Tests can be ordered as a panel, or individually.

All tests are powered by the YouScript Clinical Decision Support Tool.

 

Panels

Polypharmacy Panel
(Includes major drug metabolizing enzymes)
CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP3A5

Polypharmacy Comprehensive Panel
(Includes additional psychotropic, analgesic, cardiology, ADHD)
CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, ADRA2A, COMT, CYP1A2, CYP2B6, DPYD (DPD), F2 (Factor II), F5 (Factor V) Leiden, MTHFR, GRIK4, HTR2A, HTR2C, IFNL3 (IL28B), NAT2, OPRM1, SLCO1B1, TPMT, VKORC1

High Risk HLA Panel
HLA-A*31:01, HLA-B*15:02, HLA-B*57:01, HLA-B*58:01

 

Individual Tests

Individual tests may be ordered, please explore the menu to the left.

 

Reliability and Accuracy

Genelex has been a leader in pharmacogenetic testing since 2000. Our high-complexity laboratory facilities feature:

  • Robotic DNA extraction and testing, to ensure high accuracy and low error
  • Proprietary test platforms and methodologies
  • Testing for more allele mutations than any other system
  • Test validation across multiple platforms
  • Rapid 2-day turnaround available
  • Ability to test non-invasive swab samples or blood
  • Forensic-level protocols for sample accessioning
  • Dedicated customer support

The Genelex  laboratory is fully accredited and consistently maintains the highest standards:

  • College of American Pathologists (CAP) accreditation; 100% pass rate on CAP efficiency tests
  • Clinical Laboratory Improvement Amendments (CLIA) certification; licensed to perform testing in all U.S. states
  • State of New York Department of Health-accredited clinical laboratory for molecular genetic testing
  • Secure Laboratory Information Systems (LIS)
  • Code of Federal Regulations (CFR) 21 compliant
  • Health Insurance Portability and Accountability Act (HIPAA) compliant